| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glutathione hydrolase activity | 2.36e-11 | 9 | 59 | 5 | GO:0036374 | |
| GeneOntologyMolecularFunction | omega peptidase activity | 8.07e-10 | 16 | 59 | 5 | GO:0008242 | |
| GeneOntologyMolecularFunction | peptidyltransferase activity | 1.03e-09 | 6 | 59 | 4 | GO:0000048 | |
| GeneOntologyMolecularFunction | leukotriene-C(4) hydrolase | 1.03e-09 | 6 | 59 | 4 | GO:0002951 | |
| GeneOntologyMolecularFunction | threonine-type peptidase activity | 2.84e-09 | 20 | 59 | 5 | GO:0070003 | |
| GeneOntologyMolecularFunction | leukotriene C4 gamma-glutamyl transferase activity | 4.77e-09 | 8 | 59 | 4 | GO:0103068 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | YTHDF1 KMT2D MRTFB TIAL1 MED29 PPRC1 NUP98 MED14 SUPT20HL2 ZC3H18 MIDEAS CREBBP STRIP1 | 2.66e-05 | 1160 | 59 | 13 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription coregulator activity | 3.73e-05 | 562 | 59 | 9 | GO:0003712 | |
| GeneOntologyMolecularFunction | transcription factor binding | 6.45e-05 | 753 | 59 | 10 | GO:0008134 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | YTHDF1 KMT2D MRTFB TIAL1 MED29 PPRC1 NUP98 MED14 SUPT20HL2 ZC3H18 MIDEAS CREBBP STRIP1 | 1.32e-04 | 1356 | 59 | 13 | GO:0060090 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.66e-04 | 303 | 59 | 6 | GO:0003713 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a tRNA | 8.68e-04 | 144 | 59 | 4 | GO:0140101 | |
| GeneOntologyMolecularFunction | cGMP binding | 1.00e-03 | 16 | 59 | 2 | GO:0030553 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.42e-03 | 739 | 59 | 8 | GO:0003682 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 1.58e-03 | 20 | 59 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | adrenergic receptor binding | 2.27e-03 | 24 | 59 | 2 | GO:0031690 | |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 2.27e-03 | 24 | 59 | 2 | GO:0140517 | |
| GeneOntologyMolecularFunction | peptidase activity | 3.05e-03 | 654 | 59 | 7 | GO:0008233 | |
| GeneOntologyBiologicalProcess | leukotriene D4 biosynthetic process | 3.67e-11 | 10 | 58 | 5 | GO:1901750 | |
| GeneOntologyBiologicalProcess | glutathione catabolic process | 6.72e-11 | 11 | 58 | 5 | GO:0006751 | |
| GeneOntologyBiologicalProcess | leukotriene D4 metabolic process | 1.15e-10 | 12 | 58 | 5 | GO:1901748 | |
| GeneOntologyBiologicalProcess | leukotriene biosynthetic process | 3.74e-09 | 22 | 58 | 5 | GO:0019370 | |
| GeneOntologyBiologicalProcess | cysteine biosynthetic process | 3.91e-09 | 8 | 58 | 4 | GO:0019344 | |
| GeneOntologyBiologicalProcess | peptide modification | 1.17e-08 | 10 | 58 | 4 | GO:0031179 | |
| GeneOntologyBiologicalProcess | modified amino acid catabolic process | 6.00e-08 | 37 | 58 | 5 | GO:0042219 | |
| GeneOntologyBiologicalProcess | cysteine metabolic process | 9.99e-08 | 16 | 58 | 4 | GO:0006534 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 1.02e-07 | 41 | 58 | 5 | GO:0006691 | |
| GeneOntologyBiologicalProcess | glutathione biosynthetic process | 2.64e-07 | 20 | 58 | 4 | GO:0006750 | |
| GeneOntologyBiologicalProcess | sulfur amino acid biosynthetic process | 3.25e-07 | 21 | 58 | 4 | GO:0000097 | |
| GeneOntologyBiologicalProcess | fatty acid derivative biosynthetic process | 3.46e-07 | 52 | 58 | 5 | GO:1901570 | |
| GeneOntologyBiologicalProcess | sulfur compound catabolic process | 3.82e-07 | 53 | 58 | 5 | GO:0044273 | |
| GeneOntologyBiologicalProcess | nonribosomal peptide biosynthetic process | 3.96e-07 | 22 | 58 | 4 | GO:0019184 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | SFPQ KMT2D SATB1 EP400 MED29 BICRA SETBP1 MED25 MED14 TAF4 GNAS FOXA2 CREBBP HELLS | 4.92e-07 | 999 | 58 | 14 | GO:0071824 |
| GeneOntologyBiologicalProcess | serine family amino acid biosynthetic process | 6.81e-07 | 25 | 58 | 4 | GO:0009070 | |
| GeneOntologyBiologicalProcess | glutathione metabolic process | 9.15e-07 | 63 | 58 | 5 | GO:0006749 | |
| GeneOntologyBiologicalProcess | icosanoid biosynthetic process | 1.25e-06 | 67 | 58 | 5 | GO:0046456 | |
| GeneOntologyBiologicalProcess | peptide biosynthetic process | 2.45e-06 | 34 | 58 | 4 | GO:0043043 | |
| GeneOntologyBiologicalProcess | fatty acid derivative metabolic process | 3.41e-06 | 82 | 58 | 5 | GO:1901568 | |
| GeneOntologyBiologicalProcess | sulfur amino acid metabolic process | 4.77e-06 | 40 | 58 | 4 | GO:0000096 | |
| GeneOntologyBiologicalProcess | serine family amino acid metabolic process | 6.40e-06 | 43 | 58 | 4 | GO:0009069 | |
| GeneOntologyBiologicalProcess | modified amino acid biosynthetic process | 1.38e-05 | 52 | 58 | 4 | GO:0042398 | |
| GeneOntologyBiologicalProcess | proteinogenic amino acid biosynthetic process | 4.25e-05 | 69 | 58 | 4 | GO:0170038 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription initiation by RNA polymerase II | 4.49e-05 | 70 | 58 | 4 | GO:0060261 | |
| GeneOntologyBiologicalProcess | L-amino acid biosynthetic process | 4.49e-05 | 70 | 58 | 4 | GO:0170034 | |
| GeneOntologyBiologicalProcess | RNA polymerase II preinitiation complex assembly | 4.75e-05 | 71 | 58 | 4 | GO:0051123 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 4.92e-05 | 142 | 58 | 5 | GO:0006690 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription initiation | 6.54e-05 | 77 | 58 | 4 | GO:2000144 | |
| GeneOntologyBiologicalProcess | alpha-amino acid biosynthetic process | 6.54e-05 | 77 | 58 | 4 | GO:1901607 | |
| GeneOntologyBiologicalProcess | regulation of transcription initiation by RNA polymerase II | 7.97e-05 | 81 | 58 | 4 | GO:0060260 | |
| GeneOntologyBiologicalProcess | peptide metabolic process | 9.18e-05 | 84 | 58 | 4 | GO:0006518 | |
| GeneOntologyBiologicalProcess | transcription preinitiation complex assembly | 9.62e-05 | 85 | 58 | 4 | GO:0070897 | |
| GeneOntologyBiologicalProcess | amino acid biosynthetic process | 1.01e-04 | 86 | 58 | 4 | GO:0008652 | |
| GeneOntologyBiologicalProcess | amide biosynthetic process | 1.22e-04 | 172 | 58 | 5 | GO:0043604 | |
| GeneOntologyBiologicalProcess | regulation of DNA-templated transcription initiation | 1.25e-04 | 91 | 58 | 4 | GO:2000142 | |
| GeneOntologyBiologicalProcess | sulfur compound biosynthetic process | 1.43e-04 | 178 | 58 | 5 | GO:0044272 | |
| GeneOntologyBiologicalProcess | proteinogenic amino acid metabolic process | 1.71e-04 | 185 | 58 | 5 | GO:0170039 | |
| GeneOntologyBiologicalProcess | chromatin organization | 1.78e-04 | 896 | 58 | 10 | GO:0006325 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 2.09e-04 | 741 | 58 | 9 | GO:0006338 | |
| GeneOntologyBiologicalProcess | L-amino acid metabolic process | 2.95e-04 | 208 | 58 | 5 | GO:0170033 | |
| GeneOntologyBiologicalProcess | modified amino acid metabolic process | 3.66e-04 | 218 | 58 | 5 | GO:0006575 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | SFPQ KMT2D MRTFB MED29 PPRC1 MED25 MED14 SUPT20HL2 TAF4 FOXA2 CREBBP FOXC2 | 4.11e-04 | 1390 | 58 | 12 | GO:0045944 |
| GeneOntologyBiologicalProcess | positive regulation of transcription elongation by RNA polymerase II | 4.73e-04 | 54 | 58 | 3 | GO:0032968 | |
| GeneOntologyBiologicalProcess | hippo signaling | 4.99e-04 | 55 | 58 | 3 | GO:0035329 | |
| GeneOntologyBiologicalProcess | alpha-amino acid metabolic process | 6.95e-04 | 251 | 58 | 5 | GO:1901605 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription, elongation | 7.09e-04 | 62 | 58 | 3 | GO:0032786 | |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organism growth | 1.03e-03 | 17 | 58 | 2 | GO:0040015 | |
| GeneOntologyCellularComponent | core mediator complex | 5.04e-05 | 26 | 58 | 3 | GO:0070847 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 1.05e-04 | 272 | 58 | 6 | GO:0090575 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.35e-04 | 94 | 58 | 4 | GO:0000123 | |
| GeneOntologyCellularComponent | mediator complex | 1.47e-04 | 37 | 58 | 3 | GO:0016592 | |
| GeneOntologyCellularComponent | nuclear body | FAM193B SFPQ SATB1 EP400 RAPH1 SETBP1 NUP98 ZC3H18 CREBBP FOXC2 | 1.70e-04 | 903 | 58 | 10 | GO:0016604 |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 2.00e-04 | 104 | 58 | 4 | GO:0031248 | |
| GeneOntologyCellularComponent | transcription regulator complex | 2.27e-04 | 596 | 58 | 8 | GO:0005667 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 2.39e-04 | 109 | 58 | 4 | GO:1902493 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | SFPQ KMT2D EP400 MED29 BICRA NUP98 MED25 MED14 TAF4 MIDEAS KHDC4 CREBBP | 3.34e-04 | 1377 | 58 | 12 | GO:0140513 |
| GeneOntologyCellularComponent | chromatin | SFPQ SATB1 ZFHX4 EP400 BICRA SUPT20HL2 TAF4 FOXA2 RFX1 CREBBP HELLS FOXC2 | 6.40e-04 | 1480 | 58 | 12 | GO:0000785 |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 2.41e-03 | 96 | 58 | 3 | GO:0010494 | |
| MousePheno | abnormal circulating glutathione level | 6.10e-10 | 5 | 48 | 4 | MP:0030652 | |
| MousePheno | increased circulating glutathione level | 6.10e-10 | 5 | 48 | 4 | MP:0030653 | |
| MousePheno | glutathionuria | 6.10e-10 | 5 | 48 | 4 | MP:0013730 | |
| MousePheno | increased glutathione level | 6.10e-10 | 5 | 48 | 4 | MP:0012606 | |
| MousePheno | decreased circulating cysteine level | 4.25e-09 | 7 | 48 | 4 | MP:0030626 | |
| MousePheno | absent estrous cycle | 7.59e-09 | 44 | 48 | 6 | MP:0009009 | |
| MousePheno | decreased cysteine level | 8.48e-09 | 8 | 48 | 4 | MP:0030623 | |
| MousePheno | epididymis hypoplasia | 8.48e-09 | 8 | 48 | 4 | MP:0004932 | |
| MousePheno | nervous | 1.52e-08 | 9 | 48 | 4 | MP:0008912 | |
| MousePheno | failure of copulatory plug deposition | 2.53e-08 | 10 | 48 | 4 | MP:0030983 | |
| MousePheno | seminal vesicle hypoplasia | 2.53e-08 | 10 | 48 | 4 | MP:0005148 | |
| MousePheno | ovary hypoplasia | 2.53e-08 | 10 | 48 | 4 | MP:0005158 | |
| MousePheno | abnormal growth hormone level | 3.77e-08 | 57 | 48 | 6 | MP:0003968 | |
| MousePheno | abnormal circulating cysteine level | 3.97e-08 | 11 | 48 | 4 | MP:0030624 | |
| MousePheno | absent tertiary ovarian follicles | 3.97e-08 | 11 | 48 | 4 | MP:0011130 | |
| MousePheno | abnormal cysteine level | 8.55e-08 | 13 | 48 | 4 | MP:0030621 | |
| MousePheno | decreased glutathione level | 8.55e-08 | 13 | 48 | 4 | MP:0012604 | |
| MousePheno | abnormal glutathione level | 8.55e-08 | 13 | 48 | 4 | MP:0012603 | |
| MousePheno | priapism | 1.19e-07 | 14 | 48 | 4 | MP:0003415 | |
| MousePheno | abnormal estrous cycle | 1.58e-07 | 120 | 48 | 7 | MP:0001927 | |
| MousePheno | abnormal copulatory plug deposition | 2.16e-07 | 16 | 48 | 4 | MP:0030982 | |
| MousePheno | decreased spleen red pulp amount | 2.16e-07 | 16 | 48 | 4 | MP:0008477 | |
| MousePheno | abnormal ovulation cycle | 2.21e-07 | 126 | 48 | 7 | MP:0009344 | |
| MousePheno | short femur | 2.34e-07 | 127 | 48 | 7 | MP:0003109 | |
| MousePheno | decreased femur size | 2.74e-07 | 130 | 48 | 7 | MP:0030825 | |
| MousePheno | failure of superovulation | 3.61e-07 | 18 | 48 | 4 | MP:0031422 | |
| MousePheno | abnormal penile erection | 3.61e-07 | 18 | 48 | 4 | MP:0001379 | |
| MousePheno | oocyte degeneration | 3.61e-07 | 18 | 48 | 4 | MP:0009093 | |
| MousePheno | increased circulating growth hormone level | 4.57e-07 | 19 | 48 | 4 | MP:0005123 | |
| MousePheno | abnormal copulation physiology | 4.57e-07 | 19 | 48 | 4 | MP:0031627 | |
| MousePheno | absent erythrocytes | 7.54e-07 | 6 | 48 | 3 | MP:0000215 | |
| MousePheno | small vertebrae | 8.55e-07 | 22 | 48 | 4 | MP:0004610 | |
| MousePheno | decreased length of long bones | 9.97e-07 | 409 | 48 | 10 | MP:0004686 | |
| MousePheno | increased growth hormone level | 1.03e-06 | 23 | 48 | 4 | MP:0005137 | |
| MousePheno | uterus hypoplasia | 1.03e-06 | 23 | 48 | 4 | MP:0001121 | |
| MousePheno | abnormal copulation behavior | 1.24e-06 | 24 | 48 | 4 | MP:0009697 | |
| MousePheno | nuclear cataract | 1.73e-06 | 26 | 48 | 4 | MP:0010254 | |
| MousePheno | decreased circulating gonadotropin level | 1.83e-06 | 60 | 48 | 5 | MP:0003363 | |
| MousePheno | decreased circulating testosterone level | 1.83e-06 | 60 | 48 | 5 | MP:0002780 | |
| MousePheno | impaired ovarian folliculogenesis | 1.98e-06 | 61 | 48 | 5 | MP:0001129 | |
| MousePheno | decreased pituitary hormone level | 2.27e-06 | 113 | 48 | 6 | MP:0003972 | |
| MousePheno | diluted coat color | 2.52e-06 | 64 | 48 | 5 | MP:0000371 | |
| MousePheno | abnormal corpus luteum morphology | 2.65e-06 | 116 | 48 | 6 | MP:0002679 | |
| MousePheno | aminoaciduria | 2.73e-06 | 29 | 48 | 4 | MP:0003311 | |
| MousePheno | absent corpus luteum | 2.94e-06 | 66 | 48 | 5 | MP:0001134 | |
| MousePheno | abnormal long bone epiphyseal plate proliferative zone | 3.42e-06 | 68 | 48 | 5 | MP:0003662 | |
| MousePheno | anovulation | 4.65e-06 | 33 | 48 | 4 | MP:0008869 | |
| MousePheno | decreased circulating follicle stimulating hormone level | 5.26e-06 | 34 | 48 | 4 | MP:0002790 | |
| MousePheno | hindlimb paralysis | 7.18e-06 | 79 | 48 | 5 | MP:0000755 | |
| MousePheno | decreased hormone level | MAGEL2 LATS1 BICRA GGTLC1 GGTLC2 GNAS FOXA2 NNT CREBBP GGT2P GGT1 | 7.58e-06 | 635 | 48 | 11 | MP:0014455 |
| MousePheno | abnormal femur morphology | 7.72e-06 | 214 | 48 | 7 | MP:0000559 | |
| MousePheno | abnormal hindlimb stylopod morphology | 7.96e-06 | 215 | 48 | 7 | MP:0003856 | |
| MousePheno | decreased circulating estradiol level | 8.29e-06 | 38 | 48 | 4 | MP:0005181 | |
| MousePheno | limb paralysis | 9.16e-06 | 83 | 48 | 5 | MP:0013147 | |
| MousePheno | decreased tertiary ovarian follicle number | 9.21e-06 | 39 | 48 | 4 | MP:0011129 | |
| MousePheno | abnormal circulating testosterone level | 9.71e-06 | 84 | 48 | 5 | MP:0005180 | |
| MousePheno | abnormal circulating androgen level | 9.71e-06 | 84 | 48 | 5 | MP:0009819 | |
| MousePheno | abnormal spine curvature | 1.12e-05 | 318 | 48 | 8 | MP:0004174 | |
| MousePheno | decreased circulating estrogen level | 1.13e-05 | 41 | 48 | 4 | MP:0003371 | |
| MousePheno | induced hyperactivity | 1.24e-05 | 42 | 48 | 4 | MP:0008911 | |
| MousePheno | decreased circulating pituitary hormone level | 1.29e-05 | 89 | 48 | 5 | MP:0005118 | |
| MousePheno | decreased circulating hormone level | 1.41e-05 | 551 | 48 | 10 | MP:0014457 | |
| MousePheno | decreased follicle stimulating hormone level | 1.50e-05 | 44 | 48 | 4 | MP:0005130 | |
| MousePheno | decreased long bone epiphyseal plate size | 1.50e-05 | 44 | 48 | 4 | MP:0006396 | |
| MousePheno | abnormal testosterone level | 1.52e-05 | 92 | 48 | 5 | MP:0011385 | |
| MousePheno | abnormal tertiary ovarian follicle number | 1.96e-05 | 47 | 48 | 4 | MP:0011127 | |
| MousePheno | decreased bone mass | 2.27e-05 | 100 | 48 | 5 | MP:0004016 | |
| MousePheno | decreased thyroxine level | 2.72e-05 | 51 | 48 | 4 | MP:0005471 | |
| MousePheno | abnormal circulating estradiol level | 2.93e-05 | 52 | 48 | 4 | MP:0005183 | |
| MousePheno | aciduria | 3.67e-05 | 55 | 48 | 4 | MP:0010028 | |
| MousePheno | short tibia | 3.81e-05 | 274 | 48 | 7 | MP:0002764 | |
| MousePheno | abnormal circulating gonadotropin level | 3.93e-05 | 112 | 48 | 5 | MP:0003361 | |
| MousePheno | abnormal long bone hypertrophic chondrocyte zone | 4.10e-05 | 113 | 48 | 5 | MP:0000165 | |
| MousePheno | decreased circulating glucagon level | 4.16e-05 | 20 | 48 | 3 | MP:0002696 | |
| MousePheno | abnormal circulating estrogen level | 4.23e-05 | 57 | 48 | 4 | MP:0003369 | |
| MousePheno | abnormal tertiary ovarian follicle morphology | 4.23e-05 | 57 | 48 | 4 | MP:0009363 | |
| MousePheno | disproportionate dwarf | 4.23e-05 | 57 | 48 | 4 | MP:0002427 | |
| MousePheno | perinatal lethality, incomplete penetrance | 4.51e-05 | 503 | 48 | 9 | MP:0011090 | |
| MousePheno | abnormal urine amino acid level | 4.85e-05 | 59 | 48 | 4 | MP:0011468 | |
| MousePheno | immotile sperm | 4.85e-05 | 59 | 48 | 4 | MP:0020869 | |
| MousePheno | paralysis | 5.25e-05 | 119 | 48 | 5 | MP:0000753 | |
| MousePheno | abnormal ovarian folliculogenesis | 5.47e-05 | 120 | 48 | 5 | MP:0001130 | |
| MousePheno | decreased circulating insulin-like growth factor I level | 5.53e-05 | 61 | 48 | 4 | MP:0004701 | |
| MousePheno | abnormal ovarian follicle number | 6.43e-05 | 203 | 48 | 6 | MP:0008871 | |
| MousePheno | abnormal superovulation | 7.54e-05 | 66 | 48 | 4 | MP:0009648 | |
| MousePheno | abnormal thyroxine level | 7.54e-05 | 66 | 48 | 4 | MP:0005469 | |
| MousePheno | abnormal long bone morphology | 8.06e-05 | 676 | 48 | 10 | MP:0003723 | |
| MousePheno | abnormal pituitary hormone level | 8.61e-05 | 214 | 48 | 6 | MP:0003965 | |
| MousePheno | small epididymis | 9.50e-05 | 70 | 48 | 4 | MP:0004930 | |
| MousePheno | abnormal circulating insulin-like growth factor I level | 1.06e-04 | 72 | 48 | 4 | MP:0004700 | |
| MousePheno | hyperactivity | KMT2D SATB1 ATXN2 KCNJ3 GGTLC1 AAK1 SLC45A2 GGTLC2 GNAS FOXA2 CREBBP GGT2P GGT1 | 1.13e-04 | 1172 | 48 | 13 | MP:0001399 |
| MousePheno | abnormal limb long bone morphology | 1.15e-04 | 568 | 48 | 9 | MP:0011504 | |
| MousePheno | abnormal thyroid hormone level | 1.18e-04 | 74 | 48 | 4 | MP:0005468 | |
| MousePheno | abnormal insulin-like growth factor I level | 1.24e-04 | 75 | 48 | 4 | MP:0008831 | |
| MousePheno | kyphosis | 1.25e-04 | 229 | 48 | 6 | MP:0000160 | |
| MousePheno | abnormal skeleton development | 1.26e-04 | 447 | 48 | 8 | MP:0002113 | |
| MousePheno | abnormal hindlimb morphology | 1.28e-04 | 576 | 48 | 9 | MP:0000556 | |
| MousePheno | abnormal cartilage morphology | 1.37e-04 | 336 | 48 | 7 | MP:0000163 | |
| MousePheno | increased osteoclast cell number | 1.38e-04 | 77 | 48 | 4 | MP:0004984 | |
| MousePheno | abnormal seminal vesicle size | 1.48e-04 | 148 | 48 | 5 | MP:0004907 | |
| Domain | GGT_peptidase | 8.86e-07 | 7 | 56 | 3 | IPR000101 | |
| Domain | G_GLU_TRANSPEPTIDASE | 8.86e-07 | 7 | 56 | 3 | PS00462 | |
| Domain | G_glu_transpept | 8.86e-07 | 7 | 56 | 3 | PF01019 | |
| Domain | Ntn_hydrolases_N | 1.31e-04 | 33 | 56 | 3 | IPR029055 | |
| Domain | PDZ | 1.09e-03 | 151 | 56 | 4 | PS50106 | |
| Domain | PDZ | 1.11e-03 | 152 | 56 | 4 | IPR001478 | |
| Domain | RA | 3.88e-03 | 31 | 56 | 2 | SM00314 | |
| Domain | SNF2_N | 4.13e-03 | 32 | 56 | 2 | IPR000330 | |
| Domain | SNF2_N | 4.13e-03 | 32 | 56 | 2 | PF00176 | |
| Domain | cNMP | 4.66e-03 | 34 | 56 | 2 | SM00100 | |
| Domain | cNMP_binding | 4.66e-03 | 34 | 56 | 2 | PF00027 | |
| Domain | cNMP-bd_dom | 4.93e-03 | 35 | 56 | 2 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 4.93e-03 | 35 | 56 | 2 | PS50042 | |
| Domain | RA | 5.21e-03 | 36 | 56 | 2 | PF00788 | |
| Domain | RA | 5.50e-03 | 37 | 56 | 2 | PS50200 | |
| Domain | MYB_LIKE | 5.79e-03 | 38 | 56 | 2 | PS50090 | |
| Domain | cNMP-bd-like | 5.79e-03 | 38 | 56 | 2 | IPR018490 | |
| Pathway | REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING | 1.09e-07 | 16 | 41 | 4 | MM14680 | |
| Pathway | WP_EICOSANOID_SYNTHESIS | 4.34e-07 | 22 | 41 | 4 | MM15961 | |
| Pathway | WP_OXYLIPINS_PATHWAYS | 6.27e-07 | 24 | 41 | 4 | MM17249 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 7.45e-07 | 25 | 41 | 4 | MM14858 | |
| Pathway | REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION | 8.79e-07 | 26 | 41 | 4 | MM15190 | |
| Pathway | WP_GLUTATHIONE_METABOLISM | 1.03e-06 | 27 | 41 | 4 | MM15908 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 2.37e-06 | 33 | 41 | 4 | MM15963 | |
| Pathway | WP_GLUTATHIONE_AND_ONECARBON_METABOLISM | 3.02e-06 | 35 | 41 | 4 | MM15815 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 4.23e-06 | 38 | 41 | 4 | MM14600 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 4.71e-06 | 39 | 41 | 4 | MM15695 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 2.85e-05 | 61 | 41 | 4 | MM14861 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 1.00e-04 | 84 | 41 | 4 | M1008 | |
| Pathway | WP_OXIDATIVE_STRESS_AND_REDOX_PATHWAY | 1.43e-04 | 92 | 41 | 4 | MM15823 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 1.83e-04 | 98 | 41 | 4 | M48247 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 2.56e-04 | 107 | 41 | 4 | MM14595 | |
| Pathway | REACTOME_ADIPOGENESIS | 2.85e-04 | 110 | 41 | 4 | M48259 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 3.72e-04 | 118 | 41 | 4 | M27316 | |
| Pathway | REACTOME_DRUG_ADME | 3.84e-04 | 119 | 41 | 4 | MM15692 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 3.96e-04 | 120 | 41 | 4 | M48233 | |
| Pathway | WP_MESODERMAL_COMMITMENT_PATHWAY | 9.89e-04 | 153 | 41 | 4 | M39546 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 1.46e-03 | 170 | 41 | 4 | MM15573 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 1.71e-03 | 301 | 41 | 5 | MM15983 | |
| Pubmed | 2.55e-11 | 14 | 60 | 5 | 18357469 | ||
| Pubmed | Lung lining fluid glutathione attenuates IL-13-induced asthma. | 4.00e-11 | 5 | 60 | 4 | 18063838 | |
| Pubmed | 4.00e-11 | 5 | 60 | 4 | 10940879 | ||
| Pubmed | Cataract development in gamma-glutamyl transpeptidase-deficient mice. | 4.00e-11 | 5 | 60 | 4 | 11095909 | |
| Pubmed | 4.00e-11 | 5 | 60 | 4 | 7641802 | ||
| Pubmed | 4.00e-11 | 5 | 60 | 4 | 23615310 | ||
| Pubmed | 4.00e-11 | 5 | 60 | 4 | 9627710 | ||
| Pubmed | 4.00e-11 | 5 | 60 | 4 | 12453183 | ||
| Pubmed | 4.00e-11 | 5 | 60 | 4 | 11003618 | ||
| Pubmed | 4.00e-11 | 5 | 60 | 4 | 10392451 | ||
| Pubmed | 4.00e-11 | 5 | 60 | 4 | 2891746 | ||
| Pubmed | 4.00e-11 | 5 | 60 | 4 | 19850887 | ||
| Pubmed | Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. | 4.00e-11 | 5 | 60 | 4 | 12810527 | |
| Pubmed | Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. | 4.00e-11 | 5 | 60 | 4 | 8755578 | |
| Pubmed | Reproductive defects in gamma-glutamyl transpeptidase-deficient mice. | 4.00e-11 | 5 | 60 | 4 | 11089562 | |
| Pubmed | 4.00e-11 | 5 | 60 | 4 | 28660214 | ||
| Pubmed | Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice. | 4.00e-11 | 5 | 60 | 4 | 12468440 | |
| Pubmed | 4.00e-11 | 5 | 60 | 4 | 26977590 | ||
| Pubmed | Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia. | 4.00e-11 | 5 | 60 | 4 | 12225953 | |
| Pubmed | 4.00e-11 | 5 | 60 | 4 | 7775425 | ||
| Pubmed | Cloning of cDNA and genomic structure of the mouse gamma-glutamyl transpeptidase-encoding gene. | 4.00e-11 | 5 | 60 | 4 | 8566783 | |
| Pubmed | 4.00e-11 | 5 | 60 | 4 | 30591459 | ||
| Pubmed | 4.00e-11 | 5 | 60 | 4 | 9139708 | ||
| Pubmed | 4.00e-11 | 5 | 60 | 4 | 20622017 | ||
| Pubmed | Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice. | 4.00e-11 | 5 | 60 | 4 | 9546365 | |
| Pubmed | 4.00e-11 | 5 | 60 | 4 | 11795900 | ||
| Pubmed | 4.00e-11 | 5 | 60 | 4 | 7485380 | ||
| Pubmed | Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase. | 4.00e-11 | 5 | 60 | 4 | 10751614 | |
| Pubmed | Type VI RNA is the major gamma-glutamyl transpeptidase RNA in the mouse small intestine. | 4.00e-11 | 5 | 60 | 4 | 7523374 | |
| Pubmed | Cardio-reno-hepatic interactions in acute heart failure: the role of γ-glutamyl transferase. | 4.00e-11 | 5 | 60 | 4 | 24698228 | |
| Pubmed | Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma. | 4.00e-11 | 5 | 60 | 4 | 25132819 | |
| Pubmed | Characterization of the dwg mutations: dwg and dwg(Bayer) are new mutant alleles of the Ggt1 gene. | 4.00e-11 | 5 | 60 | 4 | 19760322 | |
| Pubmed | 4.00e-11 | 5 | 60 | 4 | 10474818 | ||
| Pubmed | 1.20e-10 | 6 | 60 | 4 | 14634009 | ||
| Pubmed | 1.20e-10 | 6 | 60 | 4 | 17363454 | ||
| Pubmed | Six mRNAs with different 5' ends are encoded by a single gamma-glutamyltransferase gene in mouse. | 1.20e-10 | 6 | 60 | 4 | 8101000 | |
| Pubmed | 1.20e-10 | 6 | 60 | 4 | 8663190 | ||
| Pubmed | Mapping of human gamma-glutamyl transpeptidase genes on chromosome 22 and other human autosomes. | 1.20e-10 | 6 | 60 | 4 | 8104871 | |
| Pubmed | 1.20e-10 | 6 | 60 | 4 | 11463821 | ||
| Pubmed | 1.20e-10 | 6 | 60 | 4 | 25326709 | ||
| Pubmed | 1.20e-10 | 6 | 60 | 4 | 12163373 | ||
| Pubmed | 1.20e-10 | 6 | 60 | 4 | 22242126 | ||
| Pubmed | 2.79e-10 | 7 | 60 | 4 | 27775020 | ||
| Pubmed | Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. | 2.79e-10 | 7 | 60 | 4 | 32284594 | |
| Pubmed | Defective epidermal growth factor gene expression in mice with polycystic kidney disease. | 2.79e-10 | 7 | 60 | 4 | 1968405 | |
| Pubmed | 2.79e-10 | 7 | 60 | 4 | 36685533 | ||
| Pubmed | SFPQ KMT2D TIAL1 EP400 MED29 ATXN2 BICRA FUBP1 MED14 TAF4 RFX1 MIDEAS KHDC4 CREBBP HELLS | 4.21e-10 | 1103 | 60 | 15 | 34189442 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 4.94e-10 | 167 | 60 | 8 | 20362541 | |
| Pubmed | 1.01e-09 | 27 | 60 | 5 | 18478268 | ||
| Pubmed | YTHDF1 KMT2D SATB1 ZFHX4 EP400 ATXN2 BICRA FUBP1 NUP98 R3HDM2 ZC3H18 TAF4 RFX1 MIDEAS CREBBP HELLS | 1.64e-09 | 1429 | 60 | 16 | 35140242 | |
| Pubmed | 1.67e-09 | 10 | 60 | 4 | 23863468 | ||
| Pubmed | KMT2D MRTFB LATS1 EP400 RAPH1 PDLIM7 MED14 TAF4 RFX1 MIDEAS CREBBP | 2.34e-09 | 549 | 60 | 11 | 38280479 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | MAGEL2 MRTFB LATS1 EP400 ATXN2 PDLIM7 BICRA KCNJ3 SETBP1 NUP98 | 3.27e-09 | 430 | 60 | 10 | 35044719 |
| Pubmed | Human lung expresses unique gamma-glutamyl transpeptidase transcripts. | 4.88e-09 | 3 | 60 | 3 | 7689219 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | YTHDF1 SFPQ KMT2D ATXN2 FUBP1 NUP98 FOXA2 MIDEAS KHDC4 CREBBP | 5.83e-09 | 457 | 60 | 10 | 32344865 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | DIP2B KMT2D LATS1 EP400 RAPH1 FUBP1 NUP98 AAK1 MED14 ZC3H18 RFX1 STRIP1 | 7.14e-09 | 774 | 60 | 12 | 15302935 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | YTHDF1 SFPQ TIAL1 EP400 ATXN2 BICRA FUBP1 NUP98 ZC3H18 TAF4 RFX1 MIDEAS HELLS | 7.20e-09 | 954 | 60 | 13 | 36373674 |
| Pubmed | 8.43e-09 | 152 | 60 | 7 | 38360978 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 9.22e-09 | 351 | 60 | 9 | 38297188 | |
| Pubmed | Gene dosage in the developing and adult brain in a mouse model of 22q11 deletion syndrome. | 2.40e-08 | 18 | 60 | 4 | 17097888 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.29e-07 | 341 | 60 | 8 | 32971831 | |
| Pubmed | 1.59e-07 | 28 | 60 | 4 | 29365100 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DIP2B MRTFB ATXN2 BICRA KCNJ3 FUBP1 SETBP1 AAK1 PDIA5 TAF4 GNAS RAPGEF2 SHROOM2 CREBBP | 1.79e-07 | 1489 | 60 | 14 | 28611215 |
| Pubmed | Cell-surface proteomics identifies lineage-specific markers of embryo-derived stem cells. | 1.84e-07 | 29 | 60 | 4 | 22424930 | |
| Pubmed | 5.65e-07 | 38 | 60 | 4 | 27820600 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 9.48e-07 | 444 | 60 | 8 | 34795231 | |
| Pubmed | 1.03e-06 | 44 | 60 | 4 | 16332269 | ||
| Pubmed | 1.10e-06 | 453 | 60 | 8 | 29656893 | ||
| Pubmed | A comprehensive analysis of 22q11 gene expression in the developing and adult brain. | 1.13e-06 | 45 | 60 | 4 | 14614146 | |
| Pubmed | SFPQ EP400 MED29 FUBP1 NUP98 MED25 MED14 ZC3H18 TAF4 CREBBP HELLS | 1.14e-06 | 1014 | 60 | 11 | 32416067 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 1.94e-06 | 857 | 60 | 10 | 25609649 | |
| Pubmed | 2.75e-06 | 56 | 60 | 4 | 20096683 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 25180444 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 25280803 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 8595911 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 37904480 | ||
| Pubmed | Role of CBP and SATB-1 in aging, dietary restriction, and insulin-like signaling. | 2.93e-06 | 2 | 60 | 2 | 19924292 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 23682772 | ||
| Pubmed | A ketogenic diet rescues hippocampal memory defects in a mouse model of Kabuki syndrome. | 2.93e-06 | 2 | 60 | 2 | 27999180 | |
| Pubmed | 4.28e-06 | 730 | 60 | 9 | 34857952 | ||
| Pubmed | An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis. | 4.64e-06 | 19 | 60 | 3 | 16799563 | |
| Pubmed | 5.01e-06 | 65 | 60 | 4 | 22496869 | ||
| Pubmed | 5.32e-06 | 66 | 60 | 4 | 23275444 | ||
| Pubmed | Human mediator subunit MED26 functions as a docking site for transcription elongation factors. | 7.97e-06 | 73 | 60 | 4 | 21729782 | |
| Pubmed | Composite co-activator ARC mediates chromatin-directed transcriptional activation. | 8.43e-06 | 23 | 60 | 3 | 10235267 | |
| Pubmed | 8.43e-06 | 23 | 60 | 3 | 9225980 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 34463256 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 28392395 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 9590171 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 15703171 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 36893259 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 12391161 | ||
| Pubmed | Different gamma-glutamyl transpeptidase mRNAs are expressed in human liver and kidney. | 8.77e-06 | 3 | 60 | 2 | 2573352 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 9858599 | ||
| Pubmed | Subunit architecture and functional modular rearrangements of the transcriptional mediator complex. | 1.23e-05 | 26 | 60 | 3 | 24882805 | |
| Pubmed | Novel critical role of a human Mediator complex for basal RNA polymerase II transcription. | 1.23e-05 | 26 | 60 | 3 | 11559591 | |
| Pubmed | 1.33e-05 | 83 | 60 | 4 | 28794006 | ||
| Pubmed | 1.73e-05 | 29 | 60 | 3 | 14638676 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 28398509 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 9194565 | ||
| Interaction | FEV interactions | 4.50e-09 | 203 | 56 | 9 | int:FEV | |
| Interaction | GGT2P interactions | 2.03e-08 | 3 | 56 | 3 | int:GGT2P | |
| Interaction | SP7 interactions | 1.46e-07 | 304 | 56 | 9 | int:SP7 | |
| Interaction | NFIX interactions | 2.04e-07 | 227 | 56 | 8 | int:NFIX | |
| Interaction | NUP35 interactions | YTHDF1 SFPQ KMT2D ATXN2 FUBP1 NUP98 FOXA2 MIDEAS KHDC4 CREBBP | 2.29e-07 | 424 | 56 | 10 | int:NUP35 |
| Interaction | EYA4 interactions | 3.43e-07 | 243 | 56 | 8 | int:EYA4 | |
| Interaction | GGT1 interactions | 6.48e-07 | 25 | 56 | 4 | int:GGT1 | |
| Interaction | DZIP3 interactions | 7.23e-07 | 183 | 56 | 7 | int:DZIP3 | |
| Interaction | GATA3 interactions | 8.36e-07 | 187 | 56 | 7 | int:GATA3 | |
| Interaction | HNF4A interactions | 8.75e-07 | 275 | 56 | 8 | int:HNF4A | |
| Interaction | HNF1B interactions | 9.30e-07 | 190 | 56 | 7 | int:HNF1B | |
| Interaction | CEBPA interactions | SFPQ KMT2D TIAL1 EP400 MED29 ATXN2 BICRA FUBP1 MED14 TAF4 RFX1 MIDEAS KHDC4 CREBBP HELLS | 9.85e-07 | 1245 | 56 | 15 | int:CEBPA |
| Interaction | GGTLC1 interactions | 1.13e-06 | 8 | 56 | 3 | int:GGTLC1 | |
| Interaction | SMC5 interactions | YTHDF1 SFPQ TIAL1 EP400 ATXN2 BICRA FUBP1 NUP98 ZC3H18 TAF4 RFX1 MIDEAS HELLS | 2.64e-06 | 1000 | 56 | 13 | int:SMC5 |
| Interaction | MEN1 interactions | YTHDF1 SFPQ KMT2D MRTFB TIAL1 EP400 FUBP1 SETBP1 NUP98 MED14 ZC3H18 RFX1 MIDEAS | 3.62e-06 | 1029 | 56 | 13 | int:MEN1 |
| Interaction | GSC interactions | 4.29e-06 | 87 | 56 | 5 | int:GSC | |
| Interaction | YAP1 interactions | SFPQ KMT2D MRTFB LATS1 PDLIM7 FUBP1 MED14 TAF4 GNAS RAPGEF2 RFX1 MIDEAS CREBBP | 7.12e-06 | 1095 | 56 | 13 | int:YAP1 |
| Interaction | EGR2 interactions | 7.81e-06 | 171 | 56 | 6 | int:EGR2 | |
| Interaction | FOXL1 interactions | 1.70e-05 | 196 | 56 | 6 | int:FOXL1 | |
| Interaction | TBXT interactions | 1.75e-05 | 116 | 56 | 5 | int:TBXT | |
| Interaction | FUBP3 interactions | 1.76e-05 | 297 | 56 | 7 | int:FUBP3 | |
| Interaction | GGTLC2 interactions | 2.27e-05 | 3 | 56 | 2 | int:GGTLC2 | |
| Interaction | YTHDF2 interactions | 2.41e-05 | 312 | 56 | 7 | int:YTHDF2 | |
| Interaction | PAX7 interactions | 2.42e-05 | 124 | 56 | 5 | int:PAX7 | |
| Interaction | MEX3B interactions | 3.42e-05 | 222 | 56 | 6 | int:MEX3B | |
| Interaction | ERG interactions | 3.51e-05 | 223 | 56 | 6 | int:ERG | |
| Interaction | GCM1 interactions | 3.81e-05 | 68 | 56 | 4 | int:GCM1 | |
| Interaction | HDAC1 interactions | SFPQ KMT2D MRTFB SATB1 ZFHX4 EP400 RAPH1 NUP98 RFX1 MIDEAS CREBBP HELLS | 4.23e-05 | 1108 | 56 | 12 | int:HDAC1 |
| Interaction | FOXP2 interactions | 4.28e-05 | 70 | 56 | 4 | int:FOXP2 | |
| Interaction | FOXQ1 interactions | 4.48e-05 | 141 | 56 | 5 | int:FOXQ1 | |
| Interaction | FAM168A interactions | 4.63e-05 | 142 | 56 | 5 | int:FAM168A | |
| Interaction | DAZL interactions | 5.12e-05 | 145 | 56 | 5 | int:DAZL | |
| Interaction | SMAD1 interactions | 5.67e-05 | 243 | 56 | 6 | int:SMAD1 | |
| Interaction | PAX6 interactions | 6.64e-05 | 366 | 56 | 7 | int:PAX6 | |
| Interaction | CRX interactions | 7.24e-05 | 254 | 56 | 6 | int:CRX | |
| Interaction | HOXD13 interactions | 7.96e-05 | 82 | 56 | 4 | int:HOXD13 | |
| Interaction | ESRRB interactions | 8.59e-05 | 262 | 56 | 6 | int:ESRRB | |
| Interaction | R3HDM1 interactions | 8.75e-05 | 84 | 56 | 4 | int:R3HDM1 | |
| Interaction | TLX1 interactions | 1.24e-04 | 175 | 56 | 5 | int:TLX1 | |
| Interaction | FOXI1 interactions | 1.25e-04 | 92 | 56 | 4 | int:FOXI1 | |
| Interaction | MED7 interactions | 1.25e-04 | 92 | 56 | 4 | int:MED7 | |
| Interaction | TEAD1 interactions | 1.28e-04 | 176 | 56 | 5 | int:TEAD1 | |
| Interaction | MED25 interactions | 1.30e-04 | 93 | 56 | 4 | int:MED25 | |
| Interaction | DYRK1A interactions | 1.34e-04 | 552 | 56 | 8 | int:DYRK1A | |
| Interaction | PUM1 interactions | 1.41e-04 | 287 | 56 | 6 | int:PUM1 | |
| Interaction | CELF1 interactions | 1.44e-04 | 288 | 56 | 6 | int:CELF1 | |
| Interaction | TOPORS interactions | 1.47e-04 | 96 | 56 | 4 | int:TOPORS | |
| Interaction | SOX9 interactions | 1.53e-04 | 97 | 56 | 4 | int:SOX9 | |
| Interaction | ALG13 interactions | 1.53e-04 | 183 | 56 | 5 | int:ALG13 | |
| Interaction | LHX2 interactions | 1.53e-04 | 183 | 56 | 5 | int:LHX2 | |
| Interaction | FOXP4 interactions | 1.59e-04 | 98 | 56 | 4 | int:FOXP4 | |
| Interaction | QKI interactions | 1.83e-04 | 190 | 56 | 5 | int:QKI | |
| Interaction | CLOCK interactions | 1.86e-04 | 102 | 56 | 4 | int:CLOCK | |
| Interaction | LHX1 interactions | 1.93e-04 | 103 | 56 | 4 | int:LHX1 | |
| Interaction | GGT5 interactions | 2.10e-04 | 8 | 56 | 2 | int:GGT5 | |
| Interaction | TADA2A interactions | 2.21e-04 | 198 | 56 | 5 | int:TADA2A | |
| Interaction | MED26 interactions | 2.23e-04 | 107 | 56 | 4 | int:MED26 | |
| Interaction | GATA2 interactions | 2.27e-04 | 199 | 56 | 5 | int:GATA2 | |
| Interaction | EN1 interactions | 2.48e-04 | 110 | 56 | 4 | int:EN1 | |
| Interaction | SMG7 interactions | 2.50e-04 | 319 | 56 | 6 | int:SMG7 | |
| Interaction | PAX8 interactions | 2.57e-04 | 111 | 56 | 4 | int:PAX8 | |
| Interaction | TBR1 interactions | 2.75e-04 | 113 | 56 | 4 | int:TBR1 | |
| Interaction | MAGEA9 interactions | 2.78e-04 | 208 | 56 | 5 | int:MAGEA9 | |
| Interaction | LPXN interactions | 2.94e-04 | 115 | 56 | 4 | int:LPXN | |
| Interaction | TRRAP interactions | 3.03e-04 | 790 | 56 | 9 | int:TRRAP | |
| Interaction | NUP43 interactions | 3.13e-04 | 625 | 56 | 8 | int:NUP43 | |
| Interaction | ONECUT1 interactions | 3.36e-04 | 10 | 56 | 2 | int:ONECUT1 | |
| Interaction | RGPD1 interactions | 3.42e-04 | 49 | 56 | 3 | int:RGPD1 | |
| Interaction | RAPGEF4 interactions | 3.63e-04 | 50 | 56 | 3 | int:RAPGEF4 | |
| Interaction | SF3B4 interactions | 3.63e-04 | 342 | 56 | 6 | int:SF3B4 | |
| Interaction | MCRIP2 interactions | 3.85e-04 | 51 | 56 | 3 | int:MCRIP2 | |
| Interaction | UBE2I interactions | 4.23e-04 | 654 | 56 | 8 | int:UBE2I | |
| Interaction | MARF1 interactions | 4.42e-04 | 128 | 56 | 4 | int:MARF1 | |
| Interaction | IGF2BP2 interactions | 4.56e-04 | 357 | 56 | 6 | int:IGF2BP2 | |
| Interaction | PAX9 interactions | 4.68e-04 | 130 | 56 | 4 | int:PAX9 | |
| Interaction | OTUD4 interactions | 4.96e-04 | 236 | 56 | 5 | int:OTUD4 | |
| Interaction | PRR13 interactions | 5.08e-04 | 56 | 56 | 3 | int:PRR13 | |
| Interaction | HDAC2 interactions | 5.86e-04 | 865 | 56 | 9 | int:HDAC2 | |
| Interaction | TOP3B interactions | YTHDF1 FAM193B KMT2D EP400 ATXN2 PPRC1 BICRA MED14 PDIA5 R3HDM2 LTBP3 GNAS | 5.97e-04 | 1470 | 56 | 12 | int:TOP3B |
| Interaction | NFIB interactions | 6.53e-04 | 142 | 56 | 4 | int:NFIB | |
| Interaction | TP53BP1 interactions | 6.57e-04 | 533 | 56 | 7 | int:TP53BP1 | |
| Interaction | SMARCC1 interactions | 6.69e-04 | 384 | 56 | 6 | int:SMARCC1 | |
| Interaction | FMR1 interactions | 6.79e-04 | 536 | 56 | 7 | int:FMR1 | |
| Interaction | PRRC2A interactions | 7.16e-04 | 389 | 56 | 6 | int:PRRC2A | |
| Interaction | ELF5 interactions | 7.43e-04 | 147 | 56 | 4 | int:ELF5 | |
| Interaction | FHL2 interactions | 7.85e-04 | 396 | 56 | 6 | int:FHL2 | |
| Interaction | SREBF1 interactions | 8.02e-04 | 150 | 56 | 4 | int:SREBF1 | |
| Interaction | WDR5 interactions | SFPQ KMT2D PDLIM7 SETBP1 NUP98 PDIA5 ZC3H18 TAF4 CREBBP HELLS | 8.14e-04 | 1101 | 56 | 10 | int:WDR5 |
| Interaction | MED23 interactions | 8.51e-04 | 266 | 56 | 5 | int:MED23 | |
| Interaction | CPEB4 interactions | 9.28e-04 | 156 | 56 | 4 | int:CPEB4 | |
| Interaction | TRO interactions | 9.35e-04 | 69 | 56 | 3 | int:TRO | |
| Interaction | S100A2 interactions | 9.64e-04 | 412 | 56 | 6 | int:S100A2 | |
| Interaction | ZC3H13 interactions | 9.73e-04 | 158 | 56 | 4 | int:ZC3H13 | |
| Interaction | MED21 interactions | 9.96e-04 | 159 | 56 | 4 | int:MED21 | |
| Interaction | MED11 interactions | 1.02e-03 | 71 | 56 | 3 | int:MED11 | |
| Interaction | MOB1A interactions | 1.06e-03 | 72 | 56 | 3 | int:MOB1A | |
| Interaction | TNRC6A interactions | 1.07e-03 | 280 | 56 | 5 | int:TNRC6A | |
| Interaction | WWTR1 interactions | 1.09e-03 | 422 | 56 | 6 | int:WWTR1 | |
| Interaction | DUXB interactions | 1.13e-03 | 18 | 56 | 2 | int:DUXB | |
| Interaction | FOXN2 interactions | 1.13e-03 | 18 | 56 | 2 | int:FOXN2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q11 | 2.42e-04 | 419 | 61 | 5 | chr22q11 | |
| Cytoband | 12q13.12 | 1.18e-03 | 38 | 61 | 2 | 12q13.12 | |
| GeneFamily | CD molecules|Gamma-glutamyltransferases | 5.91e-11 | 13 | 41 | 5 | 564 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 2.40e-05 | 25 | 41 | 3 | 775 | |
| GeneFamily | Cyclins|Mediator complex | 5.63e-05 | 33 | 41 | 3 | 1061 | |
| GeneFamily | PDZ domain containing | 3.82e-04 | 152 | 41 | 4 | 1220 | |
| GeneFamily | Forkhead boxes | 4.27e-03 | 43 | 41 | 2 | 508 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 6.43e-03 | 53 | 41 | 2 | 532 | |
| GeneFamily | RNA binding motif containing | 1.24e-02 | 213 | 41 | 3 | 725 | |
| Coexpression | BAUS_TFF2_TARGETS_UP | 4.25e-06 | 49 | 58 | 4 | MM1287 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_DN | 4.77e-06 | 111 | 58 | 5 | MM1111 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 5.33e-06 | 200 | 58 | 6 | M9889 | |
| Coexpression | ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN | 3.82e-05 | 85 | 58 | 4 | M41085 | |
| Coexpression | GAVIN_FOXP3_TARGETS_CLUSTER_P3 | 4.08e-05 | 173 | 58 | 5 | MM725 | |
| Coexpression | EIF4E_DN | 7.22e-05 | 100 | 58 | 4 | M2790 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 7.38e-05 | 466 | 58 | 7 | M13522 | |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | 7.93e-05 | 199 | 58 | 5 | M9443 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP | 9.74e-05 | 108 | 58 | 4 | MM1334 | |
| Coexpression | CADWELL_ATG16L1_TARGETS_UP | 1.28e-04 | 116 | 58 | 4 | MM1240 | |
| Coexpression | RIGGINS_TAMOXIFEN_RESISTANCE_DN | 1.30e-04 | 221 | 58 | 5 | M15835 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-07 | 185 | 59 | 6 | a2cae8c657e4f4d121476798e424876f7e247973 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-07 | 185 | 59 | 6 | d50406a9a5b8d75110ba5985741aa2293950c543 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.48e-06 | 198 | 59 | 5 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 6.80e-06 | 200 | 59 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 9.08e-06 | 191 | 58 | 6 | 4168_DN | |
| Drug | Alfadolone acetate [23930-37-2]; Down 200; 10.2uM; HL60; HT_HG-U133A | 1.08e-05 | 197 | 58 | 6 | 3127_DN | |
| Drug | AG-028671 [847803-03-6]; Down 200; 10uM; PC3; HT_HG-U133A | 1.11e-05 | 198 | 58 | 6 | 6557_DN | |
| Drug | 1-ethynylanthracene | 1.91e-05 | 3 | 58 | 2 | CID012506459 | |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 4.71e-13 | 7 | 57 | 5 | DOID:5022 (biomarker_via_orthology) | |
| Disease | alcohol dependence (biomarker_via_orthology) | 1.25e-12 | 8 | 57 | 5 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 2.39e-04 | 12 | 57 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | actinic keratosis | 3.29e-04 | 14 | 57 | 2 | EFO_0002496 | |
| Disease | Lymphoma, Large-Cell, Follicular | 3.79e-04 | 15 | 57 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 3.79e-04 | 15 | 57 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 3.79e-04 | 15 | 57 | 2 | C0079758 | |
| Disease | Lymphoma, Follicular, Grade 2 | 3.79e-04 | 15 | 57 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 3.79e-04 | 15 | 57 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 3.79e-04 | 15 | 57 | 2 | C1956130 | |
| Disease | nicotine dependence symptom count, depressive symptom measurement | 4.18e-04 | 75 | 57 | 3 | EFO_0007006, EFO_0009262 | |
| Disease | Lymphoma, Follicular | 6.81e-04 | 20 | 57 | 2 | C0024301 | |
| Disease | Adenocarcinoma of lung (disorder) | 6.82e-04 | 206 | 57 | 4 | C0152013 | |
| Disease | gastric ulcer | 7.52e-04 | 21 | 57 | 2 | EFO_0009454 | |
| Disease | glucose measurement | 8.34e-04 | 380 | 57 | 5 | EFO_0004468 | |
| Disease | cystatin C measurement | 1.07e-03 | 402 | 57 | 5 | EFO_0004617 | |
| Disease | fibrinogen measurement | 1.24e-03 | 109 | 57 | 3 | EFO_0004623 | |
| Disease | Sezary Syndrome | 1.25e-03 | 27 | 57 | 2 | C0036920 | |
| Disease | right ventricular diastolic volume measurement | 1.34e-03 | 28 | 57 | 2 | EFO_0021814 | |
| Disease | Pigmented Basal Cell Carcinoma | 1.34e-03 | 28 | 57 | 2 | C1368275 | |
| Disease | Carcinoma, Basal Cell | 1.44e-03 | 29 | 57 | 2 | C4721806 | |
| Disease | non-melanoma skin carcinoma | 1.73e-03 | 265 | 57 | 4 | EFO_0009260 | |
| Disease | dihydroxy docosatrienoic acid measurement | 1.75e-03 | 32 | 57 | 2 | EFO_0005275 | |
| Disease | peptic ulcer disease | 1.86e-03 | 33 | 57 | 2 | MONDO_0004247 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PQPILTPGQPQKIPT | 336 | P84996 | |
| TPGQPQKIPTPGQHQ | 341 | P84996 | |
| PPPGPQTTPRTAQQN | 191 | P0DSO1 | |
| KTQQPNVPIPAPPSS | 631 | Q96L91 | |
| QPLPQTQAKQPQAPP | 426 | Q2M2I8 | |
| QQQPTPVHAQPPGTP | 946 | Q92793 | |
| NVPNGPQPPQNPSMV | 711 | Q9Y2K5 | |
| QPLKPVPANVAPQSP | 881 | Q70E73 | |
| ALNGKPAPPPQSQSP | 921 | P52948 | |
| PVRKCNGQPVPFQQP | 201 | Q9NRZ9 | |
| VPQGPQAPPAQLATP | 351 | Q9UJ55 | |
| NVVPAGTVNRQPPPP | 361 | O95835 | |
| QQQAQPPPAAPAGAP | 546 | Q96AE4 | |
| QQQPPPAAANVRKPG | 186 | Q99700 | |
| QTQPQPQPQPAAPEG | 16 | A0A0U1RRL7 | |
| LQQQPPKPIPKQQGP | 211 | Q9Y6V0 | |
| IQQPTPGKPPAQQPG | 306 | Q9Y6V0 | |
| PLAQQPGTVKPPVQP | 341 | Q9Y6V0 | |
| PAQQPGPAKPPTQQV | 401 | Q9Y6V0 | |
| PQQPGSAKPPSQQPG | 491 | Q9Y6V0 | |
| SQQPGSTKPPPQQPG | 501 | Q9Y6V0 | |
| PQQPGSTKPPSQQPG | 521 | Q9Y6V0 | |
| VPPSPANFIQPGKQP | 91 | Q9BX51 | |
| PLPSLQNGPNTPNKP | 831 | Q9ULH7 | |
| VPQPDPNQPKPEGRQ | 306 | Q9P265 | |
| ATGQPQPQGTAQPPP | 601 | Q71SY5 | |
| VPPSPANFIQPGKQP | 91 | Q14390 | |
| PQPQPTPQPGAAAAQ | 406 | Q99958 | |
| PGPQQQPQPPAQLVG | 26 | Q9NX70 | |
| APPPADSAPQQNGQP | 121 | Q9NR12 | |
| GTQPLQPAPVTQPPK | 236 | B7ZAP0 | |
| APPSPANFIQPGKQP | 91 | B5MD39 | |
| QPPPQQQPFPKQPGT | 1001 | O60244 | |
| PQGFQGQQPLQKIPP | 631 | Q9HDB9 | |
| VPGPQVPPASSQPVQ | 66 | Q96PV7 | |
| PPPQPKVSSQGNLIP | 791 | Q13443 | |
| GPPKPQQLPESPSQA | 486 | Q9NS15 | |
| PPNPVAAFPPQKQQQ | 236 | Q6PJG2 | |
| QSGYPVVPPPQQPVQ | 361 | Q7Z7F0 | |
| KTALPAGPQPQPQPQ | 436 | Q7Z7F0 | |
| QGEPGALPQQPKAPQ | 381 | Q9NZM4 | |
| KNPQPPEETGPVLPQ | 371 | Q9P1V8 | |
| AKGIPPQQTPQDPPL | 246 | Q9UMX9 | |
| PVVPKEPQNPPANAA | 436 | Q5VV67 | |
| PPSPANFIQPGKQPL | 436 | P36268 | |
| LKNPQPPQPQVPETP | 256 | Q14554 | |
| SPPEPAPSPGQQQQA | 331 | Q9Y261 | |
| PPPAAQLPPIVSQGN | 211 | Q5VT03 | |
| FPAPTPKNIPQGAPV | 436 | Q13423 | |
| GQPTPLVIQQPPKPG | 736 | O00268 | |
| QATPQAPKPGPVQPL | 251 | P22670 | |
| GGPGPLIVNNKQPQP | 6 | Q5VSL9 | |
| GSQQHPPSQKAPNPP | 976 | Q13796 | |
| QQPVPGNTAEQPPSP | 271 | Q01826 | |
| LQQPTAAHPPQPGPQ | 676 | P0C7V6 | |
| PPPTPQVNQGTLGPQ | 26 | Q7Z7M1 | |
| PNSPQNKPPAAPVIN | 111 | Q9NQW8 | |
| PNQQQQAGKSPPVCP | 236 | Q96EG3 | |
| QQQPPPPPQDSSKPV | 96 | P23246 | |
| SLPQPQQQPPPAHKI | 1036 | Q9Y4G8 | |
| ASTAQPQPQPQPPKQ | 2396 | Q86UP3 | |
| QPSSPSPLQPQGPVK | 396 | Q9NS62 | |
| KPQAPAQPPQQSPPQ | 1556 | Q9Y6X0 | |
| QGQAPPPVIPPPNQA | 351 | Q01085 | |
| NKGPVPKAPVPQQAP | 276 | Q9BYJ9 | |
| PKAPVPQQAPSPQAA | 281 | Q9BYJ9 | |
| SQQPSTPQQAPPGQP | 791 | Q86VM9 | |
| TPQQAPPGQPQQGTF | 796 | Q86VM9 | |
| PPSPANFIQPGKQPL | 436 | P19440 | |
| LVQQLSPQPPQGPQG | 3786 | O14686 | |
| NNTGPQPPKPGPVLQ | 4166 | O14686 | |
| PQGPGQDPQQQLVPK | 26 | P48549 |